East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, “Cambrex”) will be exhibiting at the 2013 American Association of Pharmaceutical Sciences (AAPS) Meeting and Exposition, November 11-13 in San Antonio, Texas.
Attendees are invited to visit Cambrex’s booth to learn about the Company’s wide range of custom development and manufacturing services as well as an extensive product list of over 80 generic and branded Active Pharmaceutical Ingredients (APIs), advanced intermediates and drug delivery technologies, including Camouflage® taste-masking technology, which enhances the efficacy of finished drug products for the pharmaceutical industry.
Cambrex will be showcasing its global development and manufacturing capabilities including specialized offerings related to DEA controlled substances (Schedule II-IV), high potency APIs, high energy chemistries, biotransformation technologies and finished dosage formulations.
Cambrex also provides high quality pharmaceutical drug product formulation, development and manufacturing capabilities designed to accelerate commercialization of finished drug products for the pharmaceutical industry with specific expertise in Nicotine Replacement Therapy (NRT).
Visit us at Booth 4441 in the Henry B. Gonzalez Convention Center, San Antonio, TX.